cached image

Joshua Boger, Ph.D. - Publications

Affiliations: 
1989-2009 CEO Vertex Pharmaceuticals, Boston, MA, United States 
 2012- Alkeus Pharmaceuticals 

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
1979 Boger J, Knowles JR. Symmetrical triamino-per-O-methyl-.alpha.-cyclodextrin: a host for phosphate esters exploiting both hydrophobic and electrostatic interactions in aqueous solution Journal of the American Chemical Society. 101: 7631-7633. DOI: 10.1021/Ja00519A036  0.522
1979 Boger J, Brenner DG, Knowles JR. Symmetrical triamino-per-O-methyl-.alpha.-cyclodextrin: preparation and characterization of primary trisubstituted .alpha.-cyclodextrins Journal of the American Chemical Society. 101: 7630-7631. DOI: 10.1021/Ja00519A035  0.486
1979 Boger J, Knowles JR. Symmetrical triamino-per-O-methyl-α-cyclodextrin: A host for phosphate esters exploiting both hydrophobic and electrostatic interactions in aqueous solution [13] Journal of the American Chemical Society. 101: 7631-7633.  0.496
1978 Boger J, Corcoran RJ, Lehn J. Cyclodextrin chemistry. Selective modification of all primary hydroxyl groups of ?- and ?-cyclodextrins Helvetica Chimica Acta. 61: 2190-2218. DOI: 10.1002/Hlca.19780610622  0.439
1977 Boger J, Knowles JR. To stabilize a transition state. Ciba Foundation Symposium. 225-42. PMID 252453  0.414
Show low-probability matches.